![Illustration of a nerve cell on a colored background with light effects](https://pharmaphorum.com/wp-content/uploads/2016/06/Neuron-generic.jpg)
Alzheimer's treatment hopes take another dive as Roche drug ...
Roche's Genentech division has reported disappointing top-line results from its highly-anticipated phase 3 trial of gantenerumab in early Alzheimer's disease, in yet another setback for an